Mereo BioPharma Group plc (MREO) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q4'21 | Q2'21 | Q4'20 | Q2'20 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 500K | 0 | 0 | 0 | 0 | 0 | 1M | 533.43K | 9M | 3.56M | 832.01K | 674.99K | 0 | 0 | 25.22M | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | -100% | -100% | -100% | -100% | 20.19% | -20.97% | - | - | - | - | -100% | - | - | - | - |
| Cost of Goods Sold | 304.49K | 0 | 1K | 132K | 0 | 271.46K | 0 | 0 | 0 | -273K | 172.9K | 3.43M | 1.23M | -322.93K | 337.5K | 85.55K | 520.52K | 12.54M | 0 | 0 |
| COGS % of Revenue | - | - | - | 26.4% | - | - | - | - | - | -27.3% | 32.41% | 38.11% | 34.44% | -38.81% | 50% | - | - | 49.74% | - | - |
| Gross Profit | -304.49K | 0 | -1K | 368K | 0 | -271.46K | 0 | 0 | 0 | 1.27M | 360.53K | 5.57M | 2.34M | 1.15M | 337.5K | -85.55K | -520.52K | 12.68M | 0 | 0 |
| Gross Margin % | - | - | - | 73.6% | - | - | - | - | - | 127.3% | 67.59% | 61.89% | 65.56% | 138.81% | 50% | - | - | 50.26% | - | - |
| Gross Profit Growth % | - | 100% | - | - | - | -121.32% | -100% | -100% | -100% | 10.22% | 6.83% | 6610.74% | - | 321.88% | - | -100.67% | - | - | - | 100% |
| Operating Expenses | 8.45M | 8.39M | 10.01M | 10.87M | 11.2M | 14.86M | 9.37M | 12.81M | 9.9M | 8.4M | 7.03M | 6.38M | 8M | 25.87M | 8.9M | 28.16M | 28.04M | 12.82M | 14.28M | 10.34M |
| OpEx % of Revenue | - | - | - | 2173.4% | - | - | - | - | - | 840.1% | 1318.01% | 70.9% | 224.4% | 3109.86% | 1318.01% | - | - | 50.82% | - | - |
| Selling, General & Admin | 4.02M | 4.2M | 6.04M | 5.49M | 7.27M | 6.12M | 6.2M | 7.87M | 5.91M | 3.6M | 2.78M | 2.67M | 4.77M | 12.21M | 7.28M | 10.89M | 9.37M | 6M | 8.9M | 5.09M |
| SG&A % of Revenue | - | - | - | 1098.8% | - | - | - | - | - | 359.7% | 520.32% | 29.66% | 133.95% | 1467% | 1078.36% | - | - | 23.79% | - | - |
| Research & Development | 4.74M | 4.19M | 3.82M | 5.37M | 3.93M | 8.74M | 3.17M | 4.95M | 3.99M | 4.8M | 3.19M | 3.71M | 3.95M | 13.67M | 6.55M | 17.27M | 18.67M | 6.82M | 5.38M | 5.25M |
| R&D % of Revenue | - | - | - | 1074.6% | - | - | - | - | - | 480.4% | 597.73% | 41.24% | 110.8% | 1642.86% | 969.82% | - | - | 27.03% | - | - |
| Other Operating Expenses | -311.22K | 0 | 145K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6K | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Operating Income | -8.75M | -8.39M | -10.02M | -10.5M | -11.2M | -15.13M | -9.37M | -12.81M | -9.9M | -7.13M | -6.17M | -811K | -4.95M | -25.55M | -12.71M | -28.25M | -28.56M | -141.09K | -14.28M | -10.34M |
| Operating Margin % | - | - | - | -2099.8% | - | - | - | - | - | -712.8% | -1155.81% | -9.01% | -139.02% | -3071.05% | -1883.56% | - | - | -0.56% | - | - |
| Operating Income Growth % | 21.88% | 44.56% | -6.85% | 18.07% | -13.15% | -112.31% | -52.02% | -1480.02% | -99.82% | 72.1% | 51.51% | 97.13% | - | 10.54% | - | -19920.58% | -100.08% | 98.64% | -4.22% | 56.51% |
| EBITDA | -8.45M | -7.8M | -9.96M | -10.2M | -10.93M | -14.86M | -9.09M | -12.56M | -9.63M | -6.85M | -5.92M | -540K | -4.73M | -25.19M | -12.68M | -27.71M | -28.04M | 38.73K | -13.15M | -9.71M |
| EBITDA Margin % | - | - | - | -2040.2% | - | - | - | - | - | -684.7% | -1110.42% | -6% | -132.65% | -3027.43% | -1878.77% | - | - | 0.15% | - | - |
| EBITDA Growth % | 22.73% | 47.53% | -9.57% | 18.76% | -13.58% | -117.06% | -53.48% | -2225.37% | -103.6% | 72.82% | 53.29% | 98.05% | - | 10.17% | - | -71633.44% | -113.27% | 100.4% | -8.34% | 57.49% |
| D&A (Non-Cash Add-back) | 304.49K | 592K | 54K | 298K | 270K | 271.46K | 282K | 257K | 275K | 281K | 242.12K | 271K | 227K | 362.86K | 32.31K | 541.82K | 520.52K | 179.82K | 1.13M | 630.69K |
| EBIT | -8.75M | -7.33M | -9.87M | -14.59M | -12.71M | -7.18M | -14.65M | -11.92M | -8.64M | -9.29M | -7.52M | -722K | -11.28M | -13.21M | -14.2M | -13.27M | -14.02M | -141.09K | -14.28M | -10.34M |
| Net Interest Income | 326.45K | 398K | 473.14K | 565K | 479K | 506K | 630K | 228K | 307K | 0 | -11K | -656K | -494K | -811.44K | 741.36K | -1.97M | 1.27M | 1.31M | 2.36M | 0 |
| Interest Income | 326.45K | 421K | 500.97K | 589K | 659K | 881K | 983K | 559K | 617K | 0 | 689K | 373K | 306K | 614.15K | 741.36K | 224.25K | 1.27M | 1.31M | 2.36M | 0 |
| Interest Expense | -20K | 23K | 27.83K | 24K | 180K | 375K | 353K | 331K | 310K | 0 | 700K | 1.03M | 800K | 1.43M | 0 | 2.2M | 0 | 0 | 0 | -1.41M |
| Other Income/Expense | 1.95M | 1.04M | 2.99M | -4.12M | -1.69M | 7.58M | -5.63M | 559K | 949K | -2.51M | -1.55M | -940K | -666K | -4.95M | 2.33M | 15.63M | 32.67M | 9.32M | -13.31M | -67.78M |
| Pretax Income | -6.8M | -7.35M | -7.02M | -14.62M | -12.89M | -7.55M | -15M | -12.26M | -8.95M | -9.64M | -6.32M | -1.75M | -5.97M | -19.02M | -9.3M | -12.61M | 4.11M | 9.18M | -27.59M | -78.12M |
| Pretax Margin % | - | - | - | -2923.2% | - | - | - | - | - | -964.1% | -1185.56% | -19.46% | -167.47% | -2286.45% | -1377.84% | - | - | 36.4% | - | - |
| Income Tax | -94.84K | 0 | 0 | 0 | 0 | -570.66K | 0 | 0 | 0 | -532K | 235.58K | 0 | 453.5K | -1.36M | 45.22K | -952.73K | 3.68M | 818.89K | -916.24K | -918.16K |
| Effective Tax Rate % | 1.39% | 0% | 0% | 0% | 0% | 7.56% | 0% | 0% | 0% | 5.52% | -3.73% | 0% | -7.6% | 7.17% | -0.49% | 7.55% | 89.52% | 8.92% | 3.32% | 1.18% |
| Net Income | -6.71M | -7.35M | -7.02M | -14.62M | -12.89M | -6.98M | -15M | -12.26M | -8.95M | -9.11M | -6.56M | -1.75M | -5.51M | -17.66M | -9.35M | -24.83M | 867.99K | 8.36M | -26.67M | -77.21M |
| Net Margin % | - | - | - | -2923.2% | - | - | - | - | - | -910.9% | -1229.72% | -19.46% | -154.74% | -2122.45% | -1384.54% | - | - | 33.15% | - | - |
| Net Income Growth % | 47.95% | -5.31% | 53.18% | -19.27% | -43.97% | 23.37% | -128.68% | -599.89% | -62.3% | 48.42% | 29.81% | 92.95% | - | -2134.47% | - | -397.03% | 103.25% | 110.83% | -116.27% | -267.86% |
| Net Income (Continuing) | -6.71M | -7.35M | -7.02M | -14.62M | -12.89M | -6.98M | -15M | -12.26M | -8.95M | -9.11M | -8M | -1.75M | -12.08M | -9.57M | -10.44M | -11.66M | 430.71K | 8.36M | -26.67M | -77.21M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.04 | -0.05 | -0.04 | -0.09 | -0.08 | -0.05 | -0.10 | -430.59 | -319.56 | -278.56 | -289.06 | -69.51 | -484.10 | -424.08 | -456.09 | -499.10 | 37.01 | 773.15 | -3771.25 | -16403.28 |
| EPS Growth % | 48.78% | -2.22% | 55.38% | 99.98% | 99.97% | 99.98% | 99.97% | -519.46% | 33.99% | 34.31% | 36.62% | 86.07% | - | -1245.85% | - | -164.55% | 100.98% | 104.71% | -27.81% | -368.57% |
| EPS (Basic) | -0.04 | -0.05 | -0.04 | -0.09 | -0.08 | -0.05 | -0.10 | -430.59 | -319.56 | -278.56 | -289.06 | -69.51 | -484.10 | -384.58 | -419.08 | -499.10 | 37.01 | 848.67 | -3771.25 | -16403.28 |
| Diluted Shares Outstanding | 160.36M | 159.42M | 159.99M | 159.89M | 156.86M | 155.15M | 154.03M | 142.35M | 140.05M | 138.36M | 138.36M | 125.68M | 124.79M | 124.5M | 124.5M | 116.78M | 116.73M | 108.58M | 67.54M | 23.56M |
| Basic Shares Outstanding | 160.36M | 159.42M | 159.99M | 159.89M | 156.86M | 155.15M | 154.03M | 142.35M | 140.05M | 138.37M | 138.37M | 125.69M | 124.79M | 112.84M | 114.47M | 116.78M | 116.73M | 98.92M | 67.54M | 23.56M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |